3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
3
Neoplasms
2
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Breast Neoplasms
1
Interventions
blinatumomab
4
Rituximab
4
Cyclophosphamide
3
ponatinib
2
Vorinostat
2
Vincristine
2
Prednisone
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bortezomib
2
tetulomab tetraxetan lu-177
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
durvalumab
1
cobomarsen
1
asparaginase erwinia chrysanthemi recombinant
1
acalabrutinib
1
Methotrexate
1
Melphalan
1
Lutetium
1
Lenalidomide
1
KW-2478
1
Imatinib Mesylate
1
Hsp90 inhibitor KU757
1
Dexamethasone
1
Daunorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoproliferative Disorders
×
cirmtuzumab
×
Clear all
No trials found.